C. DeBoer

1.1k total citations · 1 hit paper
9 papers, 834 citations indexed

About

C. DeBoer is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, C. DeBoer has authored 9 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Pharmacology. Recurrent topics in C. DeBoer's work include Microbial Natural Products and Biosynthesis (3 papers), Antibiotic Resistance in Bacteria (2 papers) and Cancer therapeutics and mechanisms (1 paper). C. DeBoer is often cited by papers focused on Microbial Natural Products and Biosynthesis (3 papers), Antibiotic Resistance in Bacteria (2 papers) and Cancer therapeutics and mechanisms (1 paper). C. DeBoer collaborates with scholars based in United States. C. DeBoer's co-authors include Richard J. Wnuk, D. H. Peterson, P. A. MEULMAN, C F Nathan, Jill O’Donnell-Tormey, Karl W. Lanks, A Dietz, E. Louis Caron, J. W. Hinman and Lester A. Dolak and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

C. DeBoer

9 papers receiving 798 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GELDANAMYCIN, A NEW ANTIBIOTIC

1970 365 citations C. DeBoer, P. A. MEULMAN et al. The Journal of Antibiotics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. DeBoer United States	8	537	168	101	92	58	9	834
Tomoyoshi Hosokawa Japan	14	318 0.6×	114 0.7×	84 0.8×	35 0.4×	64 1.1×	33	629
Shigeru Hoshiko Japan	15	386 0.7×	202 1.2×	88 0.9×	134 1.5×	40 0.7×	30	851
Yaoquan Liu United States	19	647 1.2×	250 1.5×	147 1.5×	37 0.4×	44 0.8×	33	1.0k
Adorján Aszalós United States	20	556 1.0×	140 0.8×	155 1.5×	93 1.0×	79 1.4×	65	1.2k
KATSUO HATAYAMA Japan	13	432 0.8×	106 0.6×	147 1.5×	32 0.3×	98 1.7×	36	715
Saori Takahashi Japan	22	814 1.5×	111 0.7×	111 1.1×	81 0.9×	46 0.8×	95	1.6k
Teruhisa Noguchi Japan	19	539 1.0×	101 0.6×	96 1.0×	165 1.8×	42 0.7×	68	1.3k
Juan J. Martínez‐Irujo Spain	20	451 0.8×	87 0.5×	103 1.0×	70 0.8×	87 1.5×	39	966
Norbert Zimmermann Germany	19	552 1.0×	160 1.0×	54 0.5×	74 0.8×	53 0.9×	50	1.2k
Katherine N. Maloney United States	13	554 1.0×	204 1.2×	87 0.9×	43 0.5×	91 1.6×	15	1.0k

Countries citing papers authored by C. DeBoer

Since Specialization

Citations

This map shows the geographic impact of C. DeBoer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. DeBoer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. DeBoer more than expected).

Fields of papers citing papers by C. DeBoer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. DeBoer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. DeBoer. The network helps show where C. DeBoer may publish in the future.

Co-authorship network of co-authors of C. DeBoer

This figure shows the co-authorship network connecting the top 25 collaborators of C. DeBoer. A scholar is included among the top collaborators of C. DeBoer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. DeBoer. C. DeBoer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

DeBoer, C., et al.. (2002). Streptolydigin, a new antimicrobial antibiotic. I. Biologic studies of streptolydigin.. PubMed. 3. 886–92. 18 indexed citations

2.

DeBoer, C., et al.. (1998). Streptozotocin, a new antibacterial antibiotic.. PubMed. 7. 230–5. 66 indexed citations

3.

DeBoer, C., et al.. (1998). Fervenulin, a new crystalline antibiotic. I. Discovery and biological activities.. PubMed. 7. 220–6. 1 indexed citations

4.

O’Donnell-Tormey, Jill, et al.. (1987). Secretion of pyruvate. An antioxidant defense of mammalian cells.. The Journal of Experimental Medicine. 165(2). 500–514. 241 indexed citations

5.

O’Donnell-Tormey, Jill, C. DeBoer, & C F Nathan. (1985). Resistance of human tumor cells in vitro to oxidative cytolysis.. Journal of Clinical Investigation. 76(1). 80–86. 58 indexed citations

6.

Dolak, Lester A. & C. DeBoer. (1980). Clazamycin B is antibiotic 354.. The Journal of Antibiotics. 33(1). 83–84. 17 indexed citations

7.

DeBoer, C. & A Dietz. (1976). The description and antibiotic production of Streptomyces hygroscopicus var. geldanus.. The Journal of Antibiotics. 29(11). 1182–1188. 35 indexed citations

8.

DeBoer, C., P. A. MEULMAN, Richard J. Wnuk, & D. H. Peterson. (1970). GELDANAMYCIN, A NEW ANTIBIOTIC. The Journal of Antibiotics. 23(9). 442–447. 365 indexed citations breakdown →

9.

DeBoer, C., E. Louis Caron, & J. W. Hinman. (1953). AMICETIN, A NEW STREPTOMYCES ANTIBIOTIC. Journal of the American Chemical Society. 75(2). 499–500. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact